Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.2T | 2.3T | 2.5T | 2.4T |
Cost of revenue | 1.8T | 2.0T | 2.1T | 2.0T |
Gross profit | 401.6B | 300.8B | 384.7B | 378.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 121.5B | 29.2B | 108.3B | 9.4B |
Operating income | 185.8B | 47.2B | 175.8B | 230.2B |
Non operating interest income | ||||
Income | 31.7B | -37.9B | 28.0B | -7.1B |
Expense | 23.1B | -39.7B | 28.0B | -10.6B |
Other income expense | — | — | — | — |
Pretax income | 210.4B | 29.7B | 180.7B | 193.9B |
Tax provision | 50.5B | 38.7B | 42.8B | 27.0B |
Net income | 160.0B | -9.0B | 138.0B | 125.3B |
Basic EPS | 190.7 | — | 144.5 | — |
Diluted EPS | 190.7 | — | 144.5 | — |
Basic average shares | 799.0M | — | 799.0M | — |
Diluted average shares | 799.0M | — | 799.0M | — |
EBITDA | 363.0B | 155.1B | 331.1B | 297.9B |
Net income from continuing op. | 210.4B | 29.7B | 180.7B | 152.4B |
Minority interests | -7.6B | 528M | -22.5B | -1.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |